期刊
BIOTECHNOLOGY JOURNAL
卷 16, 期 3, 页码 -出版社
WILEY-V C H VERLAG GMBH
DOI: 10.1002/biot.201900438
关键词
combination therapy; ferroptosis; hypoxia; immunotherapy; mesoporous silica nanoparticles
资金
- European Research Council [ERC-2015-AdG-694160]
- Centro de Investigacion Biomedica en Red (CIBER)
Combination therapy is a promising approach for cancer treatment, with internally triggered cell-killing effects and self-triggered strategies showing potential to improve therapeutic outcomes. Combining immunotherapy, ferroptosis, and hypoxia with chemotherapeutics, especially with carriers like mesoporous silica, has led to new generation therapeutic nanomedicines capable of achieving complete tumor remission in murine models.
Combination therapy has emerged as one of the most promising approaches for cancer treatment. However, beyond remotely-triggered therapies that require advanced infrastructures and optimization, new combination therapies based on internally triggered cell-killing effects have also demonstrated promising therapeutic profiles. In this revision, the focus is on self-triggered strategies able to improve the therapeutic effect of drug delivery nanosystems. As reviewed, ferroptosis, hypoxia, and immunotherapy show potency enough to treat satisfactorily tumors in vivo. However, the interest of combining those with chemotherapeutics, especially with carriers based on mesoporous silica, has provided a new generation of therapeutic nanomedicines with potential enough to achieve complete tumor remission in murine models.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据